We are live on ! Find out more
HCMT

Highland Capital Management (Texas) Portfolio holdings

AUM $39M
This Fund
S&P 500
This Quarter Est. Return
-1.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
+$105M
Cap. Flow
+$158M
Cap. Flow %
9.22%
Top 10 Hldgs %
44.34%
Holding
408
New
98
Increased
45
Reduced
65
Closed
96

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$27.6M
2
NXRT
NexPoint Residential Trust
NXRT
+$23.8M
3
FTNT icon
Fortinet
FTNT
+$22.4M
4
ET icon
Energy Transfer Partners
ET
+$15.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$10.6M
2
VST icon
Vistra
VST
+$7.46M
3
AAL icon
American Airlines Group
AAL
+$7.31M
4
MLNX
Mellanox Technologies, Ltd.
MLNX
+$6.27M
5
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$6.01M

Sector Composition

Rank Sector Weight
1 Energy 13.75%
2 Technology 13.1%
3 Utilities 12%
4 Real Estate 8.78%
5 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIS icon
301
Oil States International
OIS
$534M
$195K 0.01%
10,650
– –
TRMT
302
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
$178K 0.01%
43,100
+19,183
+80% +$136K
GTN.A icon
303
Gray Media Inc
GTN.A
$596M
$161K 0.01%
10,436
– –
VLY icon
304
Valley National Bancorp
VLY
$8.1B
$155K 0.01%
+14,400
New +$148K
LCAHU
305
DELISTED
Landcadia Holdings II, Inc. Unit
LCAHU
$150K 0.01%
+15,000
New +$150K
EOLS icon
306
Evolus
EOLS
$500M
$146K 0.01%
10,000
– –
AGRX
307
DELISTED
Agile Therapeutics
AGRX
$146K 0.01%
50
– –
VNTR
308
DELISTED
Venator Materials PLC
VNTR
$134K 0.01%
25,250
– –
ACOR
309
DELISTED
Acorda Therapeutics
ACOR
$119K 0.01%
129
-84
-39% -$103K
LSEA
310
DELISTED
Landsea Homes
LSEA
$107K 0.01%
+10,554
New +$107K
DLNG icon
311
Dynagas LNG Partners
DLNG
$140M
$77K ﹤0.01%
52,925
– –
IMI
312
DELISTED
Intermolecular, Inc.
IMI
$23K ﹤0.01%
+19,700
New +$22.6K
ABT icon
313
Abbott
ABT
$188B
– –
-16,090
Closed -$1.29M
ACAD icon
314
Acadia Pharmaceuticals
ACAD
$5.06B
– –
-25,300
Closed -$679K
ADP icon
315
CALL
Automatic Data Processing
ADP
$109B
– –
-17,000
Closed -$2.72M
ADP icon
316
PUT
Automatic Data Processing
ADP
$109B
– –
-17,000
Closed -$2.72M
AGRO icon
317
Adecoagro
AGRO
$1.39B
– –
-230,342
Closed -$1.59M
AMGN icon
318
Amgen
AMGN
$226B
– –
-2,030
Closed -$386K
AMRN
319
CALL
Amarin Corp
AMRN
$298M
– –
-1,250
Closed -$519K
APYX icon
320
Apyx Medical
APYX
$146M
– –
-10,000
Closed -$63K
ASND icon
321
CALL
Ascendis Pharma A/S
ASND
$16.8B
– –
-20,000
Closed -$2.35M
AZO icon
322
PUT
AutoZone
AZO
$50.1B
– –
-5,000
Closed -$5.12M
BABA icon
323
PUT
Alibaba
BABA
$317B
– –
-18,000
Closed -$3.28M
BIO icon
324
PUT
Bio-Rad Laboratories Class A
BIO
$9.48B
– –
-20,000
Closed -$6.11M
CI icon
325
Cigna
CI
$73.6B
– –
-8,000
Closed -$1.29M
11 12
13
14 15

Similar funds

DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
KA
KSL Advisors Denver, Colorado $16.1M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM

Highland Capital Management (Texas)'s Q2 2019 Portfolio in Review

As of Q2 2019, Highland Capital Management (Texas) held 408 positions worth $1.71B, up 6.6% from $1.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Highland Capital Management (Texas) deployed $158M of net new capital in Q2 2019, opening 98 new positions and adding to 45 existing holdings. Its largest new stake was Bristol-Myers Squibb: 318,200 shares worth $14.4M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, up from 12% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.

  • Highland Capital Management (Texas)'s largest Q2 2019 buy was Bristol-Myers Squibb: 318,200 shares worth $14.4M.
  • Highland Capital Management (Texas) added most to Pioneer Natural Resource Co. in Q2 2019, an estimated $27.6M increase.
  • Highland Capital Management (Texas)'s biggest Q2 2019 reduction was Intel, cutting an estimated $10.6M.
  • Highland Capital Management (Texas) fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $6.27M.
  • Highland Capital Management (Texas)'s ten largest holdings make up 44% of its $1.71B portfolio in Q2 2019.
  • Highland Capital Management (Texas) opened 98 new positions and closed 96 in Q2 2019.
  • Highland Capital Management (Texas)'s portfolio value rose 6.6% quarter-over-quarter to $1.71B.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.